Press Releases

 Filter by Provider

NEW YORK, Nov. 03, 2026 (GLOBE NEWSWIRE) -- Strata Critical Medical, Inc. (Nasdaq: SRTA, "Strata" or the "Company"), today announced financial results for the third quarter ended September 30, 2026. Financial results in this release, including all comparisons to prior year periods, reflect continuing operations only.

Company to host investor conference call and webcast at 4:30 p.m. ET.

BOSTON, Nov. 03, 2026 (GLOBE NEWSWIRE) -- Tango Therapeutics, Inc. (NASDAQ: TNGX) today announced that Malte Peters, M.D., President and Chief Executive Officer of Tango Therapeutics, is scheduled to participate in a fireside chat at Guggenheim’s 3rd Annual Healthcare Innovation Conference on Tuesday, November 10, 2026 at 8:00 AM EST.

GAAP revenue decreased 1% and organic revenue was flat in the quarter;GAAP EPS of $(11.17) and adjusted EPS of $1.75 in the quarter;Company affirms 2026 organic revenue and adjusted EPS outlook;Company raises Project Elevate savings target to $1 billion, up from $500 million;Company expects to repurchase $500 million of shares in the fourth quarter of 2026

Jena, Germany, Nov. 03, 2026 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting the complement system, today is presenting its clinical development strategy and commercial vision for izicopan at the Company’s Capital Markets Day.

WATERTOWN, Mass., Nov. 03, 2026 (GLOBE NEWSWIRE) -- C4 Therapeutics, Inc. (C4T) (Nasdaq: CCCC), a clinical-stage biopharmaceutical company dedicated to advancing targeted protein degradation (TPD) science, today announced that C4T management will participate in upcoming investor conferences in November.

CAMBRIDGE, Mass., Nov. 03, 2026 (GLOBE NEWSWIRE) -- Parabilis Medicines (Nasdaq: PBLS), a clinical-stage biopharmaceutical company dedicated to creating extraordinary medicines for patients with serious diseases by unlocking historically undruggable targets, today announced that Mathai Mammen, M.D., Ph.D., Chairman, CEO and President of Parabilis Medicines, and other members of its management team, are scheduled to participate in the following investor conferences in November:

SINGAPORE, Nov. 03, 2026 (GLOBE NEWSWIRE) -- Aurora Mobile Limited (NASDAQ: JG) ("Aurora Mobile" or the "Company"), a leading provider of customer engagement and marketing technology services, today announced that its AI-first customer engagement platform, EngageLab, has partnered with SKYWORTH Solar Co., Ltd. SKYWORTH Solar has deployed EngageLab AppPush within its international business operations to streamline communications for global channel distributors, project engineering teams and end users, reinforcing its ongoing global expansion.

– Initiated dosing in a Phase 1/2 trial of ARV-6723, an immuno-oncology oral PROTAC designed to degrade HPK1, a negative regulator of immune activation –

SAN FRANCISCO and VANCOUVER, British Columbia, Nov. 03, 2026 (GLOBE NEWSWIRE) -- Jade Biosciences, Inc. (“Jade” or the “Company”) (Nasdaq: JBIO), a clinical-stage biotechnology company focused on developing best-in-class therapies for autoimmune diseases, today announced its participation in the following upcoming conferences:

ALACHUA, Fla. and TAMPA, Fla., Nov. 03, 2026 (GLOBE NEWSWIRE) -- Axogen, Inc. (Nasdaq: AXGN), a global leader in developing and marketing innovative surgical solutions for the restoration of peripheral nerve function, today announced that management is scheduled to participate in three upcoming investor conferences:

NEW YORK, Nov. 03, 2026 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today announced that it will participate in the following upcoming investor conferences in November:

Earnings Release Highlights

-- Strong U.S. launch momentum for IMCIVREE® (setmelanotide) for acquired hypothalamic obesity (HO) continues with more than 700 patient start forms as of September 30, 2026 ---- Third quarter 2026 net product revenue from global sales of IMCIVREE of $92.1 million, an increase of 29% from the prior quarter ---- Commercial launch of IMCIVREE in Japan for patients with acquired HO underway --

Envoy brings its on-site EV car-sharing amenity to the 321-unit Montage at Midtown residential community, offering residents access to Tesla Model 3 vehicles through its mobile app.

Austrian Research Promotion Agency FFG awards funding to QUANTRO to develop and implement ASCEND, an integrated artificial intelligence platform for transcription factor drug discovery

BOSTON and SAN DIEGO, Nov. 03, 2026 (GLOBE NEWSWIRE) -- Rapport Therapeutics, Inc. (Nasdaq: RAPP) (“Rapport” or the “Company”), a clinical-stage biotechnology company dedicated to the discovery and development of small molecule precision medicines for patients with neurological and psychiatric disorders, today announced that management will participate in two upcoming investor conferences.

CVR Energy, Inc. (“CVR Energy” or the “Company”) (NYSE: CVI) today announced its third quarter 2026 results including a net income attributable to CVR Energy stockholders of $570 million, or $5.67 per diluted share, and an adjusted earnings per diluted share of $4.00, compared to net income attributable to CVR Energy stockholders of $374 million, or $3.72 per diluted share, and an adjusted earnings per diluted share of 40 cents for the third quarter of 2025. Net income for the third quarter of 2026 was $563 million compared to net income of $401 million for the third quarter of 2025. Adjusted EBITDA for the third quarter of 2026 was $582 million compared to $180 million for the third quarter of 2025.

CVR Partners, LP (“CVR Partners” or the “Partnership”) (NYSE: UAN), a manufacturer of ammonia and urea ammonium nitrate (“UAN”) solution fertilizer products, today announced a net loss of $11 million, or $1.02 per common unit, and EBITDA of $20 million on net sales of $146 million for the third quarter of 2026, compared to net income of $43 million, or $4.08 per common unit, and EBITDA of $71 million on net sales of $164 million for the third quarter of 2025.

Sherwood Park, Alberta, Canada - 3rd November, 2026 - Michael Diamond’s first career was running toward emergencies as a firefighter. By age 33, he had built a multifamily real estate portfolio across Alberta valued at more than $50 million. His latest venture fits in the palm of a hand: a jar with exactly two things in it.

GUANGZHOU, CHINA: GUANGZHOU, CHINA – Media OutReach Newswire – 3 November 2026 – Co-hosted across Guangdong, Hong Kong, and Macao from October 31 to November 2, the 2026 Gre

USA Compression Partners, LP (TXSE: USAC) (“USA Compression” or the “Partnership”) announced today its financial and operating results for third-quarter 2026.

Expro Ltd (NYSE: XPRO) (the “Company” or “Expro”) today reported financial and operational results for the three months ended September 30, 2026.

Strong financial results and cash generation

Kontoor Brands, Inc. (NYSE: KTB) today announced it has completed the sale of the Lee® business to Authentic Brands Group.

PJT Partners Inc. (the “Company,” “PJT Partners,” “we,” “us,” and “our”) (NYSE: PJT) today announced its financial results for the third quarter and nine months ended September 30, 2026.

Nino Di Teodoro joins industry leaders on AI in financial crime compliance at AMLP Forum's 20th Annual European AML & FinCrime Conference, November 9-10

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the initiation of ENHANCE-3 (NCT07874815), a Phase 3 randomized clinical trial evaluating OHTUVAYRE (ensifentrine) for the prevention of chronic obstructive pulmonary disease (COPD) exacerbations in adult patients receiving standard of care (SOC) with a history of exacerbations. Recruitment of the ENHANCE-3 trial has begun, and the first patients are now enrolling in the United States.

Pfizer Inc. (NYSE: PFE) reported financial results for the third quarter of 2026 and raised its full-year 2026 guidance(2) for both Revenues and Adjusted(3) diluted EPS.

Conference call and webcast scheduled for November 3, 2026, at 8:00 a.m. EST (2:00 p.m. CET)

Aptiv PLC (NYSE: APTV) (the “Company”), a global technology company, today announced its third quarter 2026 results via an earnings release available on the Company’s Investor Relations website at https://ir.aptiv.com/financials/quarterly-results/.

Pfizer Inc. (NYSE: PFE) today announced that its Board of Directors has unanimously appointed Cecile Guegan as Chief Financial Officer and Executive Vice President, effective November 1, 2026. Cecile has served as interim Chief Financial Officer since August 16, 2026, steering the company’s financial operations, execution and strategic planning.

The Concerned Shareholders of Emerita Resources have requisitioned a special meeting to remove Joseph Belan, Oscar Cabrera and Peter McRae and elect three nominees independent of management and of the defendants in the Falcon claim: Andrew Elinesky, Norman Findlay and Wayne Peters.

Vancouver, British Columbia--(Newsfile Corp. - November 3, 2026) - Perseverance Metals Inc. (TSXV: PMI) ("Perseverance" or the "Company") is pleased to announce that it has entered into two additional agreements with Keweenaw Land Association Limited (see PMI NR Dec 18 2025 for prior transaction), an arm's length party, to lease an aggregate of 12,673.5 acres (51.3 km2) of prospective mineral titles (the "Keweenaw Leases") in the Upper Peninsula of Michigan, USA. These additional Keweenaw Leases significantly expand and infill the Company's highest priority exploration holdings in the region.

Intelligent power management company Eaton Corporation plc (NYSE:ETN) today reported strong third quarter 2026 results, including earnings per share of $2.77. Adjusted earnings per share were a record of $3.68, excluding charges of $0.62 per share related to intangible amortization, $0.30 per share related to acquisitions and divestitures, and income of $0.01 per share related to a multi-year restructuring program.

Academy Securities, the nation’s first Post-9/11 veteran owned and operated investment bank, today announced the addition of Kathryn Coulter Mitchell to its Geopolitical Intelligence Group. The Academy GIG consists of 45 US and UK Admirals & Generals, former NASA Astronauts, and former CIA/FBI Leadership. Academy has been advising clients for over a decade and is the preeminent Advisory on geostrategic risk to the markets.

InfuSystem Holdings, Inc. (NYSE American: INFU) (“InfuSystem” or the “Company”), a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, today announced that it has postponed the release of its financial results for the third quarter ended September 30, 2026, which had previously been scheduled for today.

Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, today announced its financial results for the third quarter of 2026.

Cinemark Holdings, Inc. (“Cinemark”) (NYSE: CNK), one of the largest and most influential theatrical exhibition companies in the world, today reported results for the three and nine months ended September 30, 2026.

Enpro Inc. (NYSE: NPO) today announced its financial results for the third quarter ended September 30, 2026.

JBT Marel Corporation (NYSE and Nasdaq Iceland: JBTM), a leading global technology solutions provider to high-value segments of the food & beverage industry, today reported financial results for the third quarter of 2026.

Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to unlocking urgently needed new treatment options in mental health care, today reported the third quarter 2026 financial results and business highlights.

Walker & Dunlop, Inc. announced today that it has arranged $109,900,000 in financing for Wyndchase Aspen Grove, a 560-unit multifamily community located in Franklin, Tennessee.

Zebra Technologies Corporation (NASDAQ: ZBRA), a global leader in digitizing and automating workflows to deliver intelligent operations, today announced results for the third quarter ended October 3, 2026.

Dynatrace (NYSE: DT), the leading AI-powered observability platform, today announced financial results for the second quarter of fiscal 2027 ended September 30, 2026.

COCONUT CREEK, Fla., Nov. 03, 2026 (GLOBE NEWSWIRE) -- Willis Lease Finance Corporation (NASDAQ: WLFC) (“WLFC” or the “Company”), the leading lessor of commercial aircraft engines and global provider of aviation services, today announced its financial results for the third quarter ended September 30, 2026.

NEW YORK, Nov. 03, 2026 (GLOBE NEWSWIRE) -- Apollo Global Management, Inc. (NYSE: APO) (together with its consolidated subsidiaries, “Apollo”) today reported results for the third quarter ended September 30, 2026.

“Uniqueness, innovation and focus: three key factors to keep the promises of our last Capital Markets Day. Deliveries of our F80 supercar and personalizations, led by the Ferrari 296 Speciale family, support our robust financial growth and reflect our clients’ ever-deepening desire to make each Ferrari uniquely their own. Building on this solid foundation, we are further raising our full-year guidance,” said Benedetto Vigna, CEO of Ferrari. “Our order book now reaches into 2028, and we still have two more launches to come this year. In addition, we continue to create engaging events around the world to further tighten the bonds with our clients and partners across Racing, Sports Cars and Lifestyle”.